Table 5 Cancer-associated venous thrombosis risk by Khorana score for the analyzed patients
Khorana score (KS) | Number of patients (%) | Patients without VTE | Patients with VTE (% in each score group) |
|---|---|---|---|
0 (low risk) | 4,801 (41.0%) | 4,764 | 37 (0.77%) |
1 ~ 2 (intermediate risk) | 6,023 (52.3%) | 5,890 | 133 (2.26%) |
1 | 3,699 (31.6%) | 3,624 | 75 (2.03%) |
2 | 2,324 (19.8%) | 2,266 | 58 (2.50%) |
≥ 2a) | 3,214 (27.4%) | 3,119 | 95 (2.96%) |
≥ 3 (high risk) | 890 (7.6%) | 853 | 37 (4.16%) |
Total | 11,714 (100%) | 11,507 | 207 (1.79%) |